DFTX
NA
$21.27
+$0.29(+1.38%)
57
Overall
60
Value
91
Tech
21
Quality
Market Cap
$2.16B
Volume
1.32M
52W Range
$6.03 - $26.25
Target Price
$38.87
Company Overview
| Mkt Cap | $2.16B | Price | $21.27 |
| Volume | 1.32M | Change | +1.38% |
| P/E Ratio | -19.9 | Open | $20.83 |
| Revenue | -- | Prev Close | $20.98 |
| Net Income | $-108.7M | 52W Range | $6.03 - $26.25 |
| Div Yield | N/A | Target | $38.87 |
| Overall | 57 | Value | 60 |
| Quality | 21 | Technical | 91 |
No chart data available
Latest News
Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (DFTX) and Cabaletta Bio (CABA)
Brian Anderson•12 hours ago
3 Different Ways to Play the Rally in Psychedelic Stocks
TheStreet Pro•4 days ago
Definium Therapeutics (DFTX) Gets a Buy from H.C. Wainwright
TipRanks Auto-Generated Intelligence Newsdesk•6 days ago
Oppenheimer Sticks to Their Buy Rating for Definium Therapeutics (DFTX)
TipRanks Auto-Generated Intelligence Newsdesk•6 days ago
Canaccord Genuity Keeps Their Buy Rating on Definium Therapeutics (DFTX)
TipRanks Auto-Generated Intelligence Newsdesk•6 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DFTX | $21.27 | +1.4% | 1.32M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |